» Articles » PMID: 23105570

Sialic Acid in Cardiovascular Diseases

Overview
Specialty Biochemistry
Date 2012 Oct 30
PMID 23105570
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Sialic acid, the acylated derivatives of 9-carbon sugar neuraminic acid, present as terminal component of oligosaccharide chains of many glycoproteins and glycolipids, has been recognized to be involved in the regulation of a great variety of biological phenomena. Studies have shown that serum sialic acid predicts both coronary heart disease and stroke mortality and reflects the existence or activity of an atherosclerotic process. Most of the studies have shown an elevation in serum sialic acid concentration in coronary heart disease and a positive correlation between the raised serum sialic acid and the severity of the coronary lesions is observed. However, a few contradictory reports are also available. Racial differences in serum sialic acid have also been reported and correlated with international differences in the prevalence of atherosclerosis. Reduced sialic acid content of platelets, erythrocytes and lipoproteins may play important role in the pathogenesis of atherosclerosis. Elucidation of the mechanism of alternation in sialic acid concentration may throw more light on its potential clinical utility. Hence more studies are needed to designates sialic acid as a cardiovascular risk factor/marker.

Citing Articles

Sialic acid: an attractive biomarker with promising biomedical applications.

Doostkam A, Malekmakan L, Hosseinpour A, Janfeshan S, Roozbeh J, Masjedi F Asian Biomed (Res Rev News). 2023; 16(4):153-167.

PMID: 37551166 PMC: 10321195. DOI: 10.2478/abm-2022-0020.


The secretome as a biomarker and functional agent in heart failure.

Nyarko O, Sucharov C J Cardiovasc Aging. 2023; 3(3).

PMID: 37484982 PMC: 10361342. DOI: 10.20517/jca.2023.15.


Elevated Serum Sialic Acid Levels May be Associated With Diabetes Retinopathy: A Cross-Sectional Study in Ghana.

Owiredu W, Obirikorang C, Agoe A, Acheampong E, Anto E, Amanquah S Front Clin Diabetes Healthc. 2023; 3:871051.

PMID: 36992772 PMC: 10012103. DOI: 10.3389/fcdhc.2022.871051.


Sialic acid biosensing by post-printing modification of PEDOT:PSS with pyridylboronic acid.

Fujisaki H, Matsumoto A, Miyahara Y, Goda T Sci Technol Adv Mater. 2022; 23(1):525-534.

PMID: 36147749 PMC: 9487965. DOI: 10.1080/14686996.2022.2122867.


Glycosylation and Aging.

Cindric A, Kristic J, Kavur M, Pezer M Adv Exp Med Biol. 2021; 1325:341-373.

PMID: 34495544 DOI: 10.1007/978-3-030-70115-4_17.


References
1.
Cohen N, Ekholm J, Luthra M, HANAHAN D . Biochemical characterization of density-separated human erythrocytes. Biochim Biophys Acta. 1976; 419(2):229-42. DOI: 10.1016/0005-2736(76)90349-7. View

2.
Pickup J, Mattock M . Activation of the innate immune system as a predictor of cardiovascular mortality in Type 2 diabetes mellitus. Diabet Med. 2003; 20(9):723-6. DOI: 10.1046/j.1464-5491.2003.00990.x. View

3.
Kruth H . The fate of lipoprotein cholesterol entering the arterial wall. Curr Opin Lipidol. 1997; 8(5):246-52. DOI: 10.1097/00041433-199710000-00002. View

4.
Resnitzky P, Yaari A, Danon D . Biophysical characteristics of erythrocytes during acute myocardial infarction and venous thrombosis. Thromb Diath Haemorrh. 1972; 28(3):524-32. View

5.
Orekhov A, Tertov V, Mukhin D, Mikhailenko I . Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochem Biophys Res Commun. 1989; 162(1):206-11. DOI: 10.1016/0006-291x(89)91982-7. View